PTC Therapeutics (PTCT) News Today

PTC Therapeutics, Inc. (NASDAQ:PTCT) shares are trading higher amid a mix of upward price‐target revisions and downward earnings‐estimate adjustments from major analysts ahead of its Q2 report.

• Positive Sentiment: Cantor Fitzgerald lifted its PTCT price target to $120.00 following its “Overweight” rating. Cantor Fitzgerald Raises PTCT Price Target
• Positive Sentiment: UBS Group boosted its PTCT price target to $80.00 in its latest coverage update. UBS Group Raises Price Target
• Positive Sentiment: Analysts raised PTCT’s price target to $46.00, signaling growing confidence in near‐term catalysts. Price Target Raised to $46.00
• Positive Sentiment: Another firm increased its PTCT price target to $84.00, reflecting optimism around product launches. Price Target Raised to $84.00
• Positive Sentiment: Zacks expects PTCT to beat Q2 earnings estimates based on strong revenue drivers and pipeline prospects. Expected to Beat Earnings Estimates
• Neutral Sentiment: PTC Therapeutics will report Q2 2025 results after market close on August 7. PTCT to Release Q2 Earnings
• Neutral Sentiment: William Blair published Q3 2025 EPS forecasts of ($1.51) per share, alongside quarterly and full‐year 2026 outlooks. Q3 Earnings Estimate by William Blair
• Neutral Sentiment: William Blair issued a separate Q3 earnings forecast for PTCT, reiterating its guidance across 2025‒2026 periods. Q3 Earnings Forecast by William Blair
• Neutral Sentiment: Multiple analysts provided FY2025 earnings predictions for PTCT, reflecting a range of outcomes ahead of the results. Analysts Offer FY2025 Earnings Predictions
• Neutral Sentiment: Research houses issued varied FY2025 EPS forecasts for PTCT, underscoring mixed views on growth drivers. Research Analysts Issue FY2025 Forecasts
• Negative Sentiment: Cantor Fitzgerald cut its FY2026 EPS estimate for PTCT to ($4.36) from ($3.22), below consensus of ($4.52). Cantor Fitzgerald FY2026 EPS Cut
• Negative Sentiment: Cantor Fitzgerald trimmed its FY2025 EPS outlook to $8.16 from $8.20, reflecting softer near‐term profitability expectations. Cantor Fitzgerald FY2025 EPS Cut
• Negative Sentiment: William Blair lowered its FY2025 EPS estimate for PTCT to $6.00 from $6.14, signaling concerns on cost pressures. William Blair FY2025 EPS Cut